Literature DB >> 9743416

Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin.

A Koster1, H Kuppe, R Hetzer, R Sodian, G J Crystal, F Mertzlufft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9743416     DOI： 10.1097/00000542-199809000-00029

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

Review 1.  Management of patients with heparin-induced thrombocytopenia: focus on recombinant hirudin.

Authors:  N Lubenow; A Greinacher
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

Review 2.  Thrombin inhibitors and cardiopulmonary bypass.

Authors:  Alan Merry
Journal:  J Extra Corpor Technol       Date:  2006-03

Review 3.  Hirudin-based anticoagulant strategies for patients with suspected heparin-induced thrombocytopenia undergoing percutaneous coronary interventions and bypass grafting.

Authors:  R C Becker
Journal:  J Thromb Thrombolysis       Date:  2000-11       Impact factor: 2.300

4.  Why is the platelet count low: should I be concerned about heparin-induced thrombocytopenia?

Authors:  Christopher Lancaster; Joseph D Tobias
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01

5.  Recombinant hirudin treatment modulates aquaporin-4 and aquaporin-9 expression after intracerebral hemorrhage in vivo.

Authors:  Zhe Sun; Zhenhuan Zhao; Shiguang Zhao; Yi Sheng; Zonghang Zhao; Cheng Gao; Jingwen Li; Xiangzhen Liu
Journal:  Mol Biol Rep       Date:  2008-06-24       Impact factor: 2.316
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.